R&D AI in clinical development & ‘white space’, with Andrew Mack... Andrew Mackinnon, senior vice president and executive general manager at Medable, discusses leveraging AI to transform & accelerate development.
Patients Simplifying care to close the gap: Rethinking treatment burd... Simplifying the complexity of medical treatments extends beyond convenience to improving equity.
Patients Why inclusive engagement is key to closing health gaps Over the summer, the People Centric Advocacy Model (PCAM) launched, a new approach to tackling health inequalities.
R&D Mind the gap: The need for gender-specific outcome measureme... It is well documented that women face delayed diagnoses, mischaracterised symptoms, and experience more years of ill-health compared to men.
Digital What is the future of technology in health data? From robot-assisted surgery to personalised disease treatment - technology can do some truly remarkable things.
Market Access Health equity can be a competitive advantage: What pharma le... As NICE begins to incorporate health equity into drug reimbursement decisions, forward-looking pharmaceutical companies have a chance to lead – aligning innovation with access drivers and g
News Regenxbio, Solid report data with Duchenne gene therapies Regenxbio and Solid Bio say their gene therapies for Duchenne muscular dystrophy show no sign so far of the liver issues seen with Sarepta's Elevidys.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.